reported that sGC agonist showed anti-inflammatory and antifibrotic effects by suppressing the transformation of stellate cells into myofibroblasts in models of nonalcoholic steatohepatitis. Here, SGCB is linked to metabolic dysfunction-associated steatohepatitis.